Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00249548
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2005-11-03
Brief Title:
Low-Cost Contingency Management for Hispanic Outpatients - 3
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Low-Cost Contingency Management for Hispanic Outpatients
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectiveness of a lower-cost contingency management CM procedure in Hispanic substance abusing outpatients Thirty individuals meeting DSM-IV criteria for substance dependence receive one of two conditions a standard treatment or b standard treatment plus prize CM Using a cross-over design CM is implemented in a community-based outpatient clinic and compared with non-CM in the same clinic The participating clinic is randomly assigned to receive either the CM or non-CM phase first 15 weeks after the final participant in one phase is enrolled a one-week washout period occurs followed by a switch to the other phase Patients initiating outpatient treatment during the non-CM phase receive standard treatment and submit urine and breath samples 2week during Weeks 1-6 and 1week during Weeks 7-12 Patients initiating treatment during the CM phase also receive standard treatment and the same breath and urine monitoring In addition they earn the opportunity to win prizes for coming to treatment and for submitting negative breath and urine samples Follow-up interviews are conducted at 136 and 9 months following intake during which substance use and psychosocial functioning are assessed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-13444-3 | None | None | None |